Corcept Therapeutics | CORT - 营业费用



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 11.92B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


营业费用 更改 日
Acadia Pharmaceuticals USD 270.12M 2.55M 2026-06
Alaunos Therapeutics USD 1.01M 175K 2026-03
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Ardelyx USD 127.27M 7.15M 2026-03
Aurora Cannabis CAD 48.04M 81.94M 2026-03
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Eli Lilly USD 10.52B 496M 2026-06
J&J USD 17.83B 388M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Merck USD 15.77B 2.4B 2026-06
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novartis USD 10.2B 912M 2026-06
Novartis USD 9.29B 507M 2026-03
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 180.54M 7.79M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06